This morning, Remedy disclosed that it is getting a €15 million convertible loan from a Tencent affiliate. The loan is subject to approval by the Remedy board during the Extraordinary General Meeting, which is slated for October 24. The loan includes an 8% annual non-cash interest and has a fixed conversion rate of EUR 27.2 per share, a 63.86% premium over the closing price for Remedy's shares on Nasdaq Helsinki as of yesterday's closing. The conversion part means Tencent can choose to get Remedy shares instead, up to 811K of them, which would amount to nearly 6% of total shares. […]
Read full article at https://wccftech.com/remedy-is-getting-a-e15-million-loan-from-tencent/
WccftechContinue reading/original-link]